Reglan Adverse Events More Than Doubled from 2006 to 2008

more+

less-

7/7/2009

Hissey Kientz LLP Contact

Send

Recent data from the Food and Drug Administration’s Adverse Event

Reporting System reveals that new cases of tardive dyskinesia or other movement disorders reported by users of Reglan (or its generic version, metoclopramide) more than doubled between 2006 and 2008, according to an analysis by Hissey Kientz, LLP. This represents a substantial increase in new adverse events related to Reglan.

Download PDF[19KB]
Download Word[175KB]
Email
Report

LOADING PDF: If there are any problems, click here to download the file.

Published In: Consumer Protection Updates, Health Law Updates, Law Firm Marketing Updates, Personal Injury Updates, Products Liability Updates

Send Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.